Discover how Lactobacillus coryniformis MXJ32, a promising probiotic, shows remarkable potential in preventing colitis-associated colorectal cancer by reshaping the gut microbiome and reducing inflammation.
Explore how gut microbiome differences between colorectal cancer patients and healthy volunteers reveal new insights into cancer detection and treatment.